Daxin Materials Corp
TWSE:5234
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Daxin Materials Corp
TWSE:5234
|
TW |
|
S
|
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
|
CN |
|
W R Berkley Corp
NYSE:WRB
|
US |
|
Zhejiang Natural Outdoor Goods Inc
SSE:605080
|
CN |
|
Shandong Sun Paper Co Ltd
SZSE:002078
|
CN |
|
Target Corp
NYSE:TGT
|
US |
|
FS Development Investment Holdings
SZSE:300071
|
CN |
Balance Sheet
Balance Sheet Decomposition
Daxin Materials Corp
Daxin Materials Corp
Balance Sheet
Daxin Materials Corp
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
290
|
438
|
493
|
250
|
407
|
330
|
206
|
189
|
222
|
198
|
351
|
333
|
284
|
215
|
211
|
244
|
195
|
247
|
|
| Cash |
0
|
0
|
493
|
0
|
0
|
145
|
160
|
89
|
152
|
143
|
106
|
143
|
134
|
185
|
211
|
244
|
155
|
247
|
|
| Cash Equivalents |
290
|
438
|
0
|
250
|
407
|
185
|
46
|
100
|
70
|
55
|
245
|
190
|
150
|
30
|
0
|
0
|
40
|
0
|
|
| Short-Term Investments |
7
|
29
|
1
|
184
|
269
|
490
|
490
|
467
|
391
|
410
|
431
|
535
|
953
|
941
|
1 073
|
1 213
|
1 471
|
1 525
|
|
| Total Receivables |
396
|
865
|
885
|
922
|
1 212
|
1 179
|
1 194
|
1 170
|
1 257
|
1 339
|
1 443
|
1 325
|
1 228
|
1 322
|
1 014
|
1 069
|
1 133
|
1 174
|
|
| Accounts Receivables |
391
|
856
|
881
|
922
|
1 212
|
1 179
|
1 194
|
1 170
|
1 257
|
1 339
|
1 443
|
1 325
|
1 228
|
1 322
|
1 014
|
1 069
|
1 133
|
1 174
|
|
| Other Receivables |
5
|
9
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
38
|
58
|
67
|
118
|
190
|
186
|
224
|
199
|
191
|
214
|
271
|
286
|
286
|
356
|
364
|
338
|
380
|
416
|
|
| Other Current Assets |
1
|
51
|
58
|
38
|
24
|
31
|
21
|
23
|
24
|
28
|
50
|
27
|
32
|
38
|
28
|
37
|
81
|
60
|
|
| Total Current Assets |
731
|
1 440
|
1 504
|
1 511
|
2 101
|
2 216
|
2 134
|
2 048
|
2 085
|
2 187
|
2 546
|
2 507
|
2 782
|
2 872
|
2 690
|
2 902
|
3 259
|
3 422
|
|
| PP&E Net |
134
|
192
|
618
|
784
|
764
|
770
|
1 087
|
1 148
|
1 082
|
1 266
|
1 326
|
1 551
|
1 544
|
1 755
|
1 783
|
1 708
|
1 635
|
1 640
|
|
| PP&E Gross |
134
|
192
|
618
|
784
|
764
|
770
|
1 087
|
1 148
|
1 082
|
1 266
|
1 326
|
1 551
|
1 544
|
1 755
|
1 783
|
1 708
|
1 635
|
1 640
|
|
| Accumulated Depreciation |
48
|
81
|
114
|
170
|
269
|
370
|
488
|
572
|
702
|
854
|
1 023
|
1 221
|
1 425
|
1 632
|
1 836
|
2 083
|
2 294
|
2 526
|
|
| Intangible Assets |
4
|
2
|
1
|
1
|
2
|
1
|
1
|
3
|
2
|
5
|
3
|
3
|
3
|
3
|
2
|
2
|
3
|
5
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
5
|
15
|
13
|
13
|
12
|
10
|
10
|
10
|
10
|
10
|
9
|
27
|
27
|
|
| Other Long-Term Assets |
5
|
44
|
64
|
56
|
32
|
10
|
9
|
8
|
7
|
6
|
5
|
7
|
10
|
10
|
14
|
21
|
26
|
20
|
|
| Total Assets |
873
N/A
|
1 678
+92%
|
2 187
+30%
|
2 351
+8%
|
2 899
+23%
|
3 003
+4%
|
3 247
+8%
|
3 220
-1%
|
3 189
-1%
|
3 476
+9%
|
3 891
+12%
|
4 078
+5%
|
4 349
+7%
|
4 650
+7%
|
4 500
-3%
|
4 642
+3%
|
4 949
+7%
|
5 113
+3%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
264
|
627
|
567
|
507
|
602
|
665
|
722
|
706
|
652
|
666
|
669
|
525
|
563
|
604
|
476
|
420
|
510
|
499
|
|
| Accrued Liabilities |
41
|
121
|
200
|
179
|
241
|
271
|
249
|
251
|
254
|
312
|
379
|
0
|
264
|
272
|
249
|
299
|
350
|
436
|
|
| Short-Term Debt |
0
|
80
|
10
|
0
|
0
|
0
|
55
|
0
|
0
|
50
|
30
|
50
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
42
|
109
|
119
|
88
|
105
|
152
|
0
|
0
|
0
|
8
|
8
|
22
|
107
|
105
|
153
|
124
|
|
| Other Current Liabilities |
19
|
37
|
67
|
103
|
98
|
103
|
39
|
45
|
142
|
100
|
167
|
519
|
270
|
309
|
276
|
264
|
253
|
301
|
|
| Total Current Liabilities |
325
|
864
|
885
|
898
|
1 061
|
1 127
|
1 170
|
1 154
|
1 048
|
1 127
|
1 245
|
1 102
|
1 105
|
1 207
|
1 108
|
1 088
|
1 266
|
1 360
|
|
| Long-Term Debt |
0
|
8
|
206
|
173
|
120
|
16
|
180
|
108
|
16
|
32
|
0
|
194
|
343
|
375
|
443
|
420
|
397
|
224
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
325
N/A
|
872
+168%
|
1 092
+25%
|
1 073
-2%
|
1 183
+10%
|
1 143
-3%
|
1 351
+18%
|
1 263
-7%
|
1 065
-16%
|
1 159
+9%
|
1 245
+7%
|
1 296
+4%
|
1 449
+12%
|
1 582
+9%
|
1 551
-2%
|
1 507
-3%
|
1 665
+10%
|
1 586
-5%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
616
|
617
|
670
|
802
|
889
|
889
|
934
|
934
|
934
|
934
|
1 027
|
1 027
|
1 027
|
1 027
|
1 027
|
1 027
|
1 027
|
1 027
|
|
| Retained Earnings |
68
|
161
|
388
|
428
|
608
|
929
|
922
|
984
|
1 150
|
1 343
|
1 578
|
1 715
|
1 833
|
2 000
|
1 881
|
2 066
|
2 215
|
2 459
|
|
| Additional Paid In Capital |
0
|
4
|
23
|
47
|
220
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
|
| Other Equity |
0
|
25
|
15
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Equity |
548
N/A
|
806
+47%
|
1 096
+36%
|
1 278
+17%
|
1 716
+34%
|
1 859
+8%
|
1 896
+2%
|
1 958
+3%
|
2 124
+9%
|
2 317
+9%
|
2 646
+14%
|
2 783
+5%
|
2 900
+4%
|
3 067
+6%
|
2 949
-4%
|
3 135
+6%
|
3 284
+5%
|
3 528
+7%
|
|
| Total Liabilities & Equity |
873
N/A
|
1 678
+92%
|
2 187
+30%
|
2 351
+8%
|
2 899
+23%
|
3 003
+4%
|
3 247
+8%
|
3 220
-1%
|
3 189
-1%
|
3 476
+9%
|
3 891
+12%
|
4 078
+5%
|
4 349
+7%
|
4 650
+7%
|
4 500
-3%
|
4 642
+3%
|
4 949
+7%
|
5 113
+3%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
91
|
91
|
91
|
93
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
|